Aushon Biosystems Inc., a Burlington, Mass.-based developer of enabling technologies for life science research, drug discovery/development and clinical diagnostics, has secured $4 million of a $7 million Series B round, according to a regulatory filing. Return backer North Bridge Venture Partners is the only institutional shareholder listed. www.aushonbiosystems.com
If you do not receive this within five minutes, please try and sign in again. If the problem persists, please
email: subscriptions@peimedia.com.